Neurobiological aspects of social anxiety disorder

Israel Journal of Psychiatry and Related Sciences

Volumn 46, Issue 1, 2009, Pages 5-12

  Furmark, Tomas ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77952573566     PISSN: 03337308     EISSN: 26172402     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Fehm L, Pelissolo A, Furmark T, Wittchen H-U. Size and burden of social phobia in Europe. Eur Neuropsychopharmacol 2005;15:453-462.
2. Phelps EA, LeDoux JE. Contributions of the amygdala to emotion processing: From animal models to human behavior. Neuron 2005;48:175-187.
3. Davis M, Whalen PJ. The amygdala: vigilance and emotion. Mol Psychiatry 2001;6:13-34.
4. Tillfors M, Furmark T, Marteinsdottir I, Fischer H, Pissiota A, Långström B, Fredrikson M. Cerebral blood flow in subjects with social phobia during stressful speaking tasks: A PET-study. Am J Psychiatry 2001;158:1220-1226.
5. Hirsch CR, Clark DM. Information-processing bias in social phobia. Clin Psychol Rev 2004;24:799-825.
6. Lissek S, Levenson J, Biggs AL, Johnson LL, Ameli R, Pine DS, Grillon C. Elevated fear conditioning to socially relevant unconditioned stimuli in social anxiety disorder. Am J Psychiatry 2008;165:124-132.
7. Charney DS, Deutch A. Functional neuroanatomy of anxiety and fear: Implications for the pathophysiology and treatment of anxiety disorders. Crit Rev Neurobiol 1996;10:419-446.
8. Ochsner KN, Gross JJ. The cognitive control of emotion. Trends Cogn Sci 2005;9:242-249.
9. Stein JL, Wiedholz LM, Bassett DS, Weinberger DR, Zink CF, Mattay VS, Meyer-Lindenberg A. A validated network of effective amygdala connectivity. Neuroimage 2007;36:736-745.
10. Pezawas L, Meyer-Lindenberg A, Drabant EM, Verchinski BA, Munoz KE, Kolachana BS, Egan MF, Mattay VS, Hariri AR, Weinberger DR. 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: A genetic susceptibility mechanism for depression. Nat Neurosci 2005;8:828-834.
11. Stein MB, Simmons AN, Feinstein JS, Paulus MP. Increased amygdala and insula activation during emotion processing in anxiety-prone subjects. Am J Psychiatry 2007;164:318-327.
12. Phan KL, Wager T, Taylor SF, Liberzon I. Functional neuroanatomy of emotion: A meta-analysis of emotion activation studies in PET and fMRI. Neuroimage 2002;16:331-348.
13. Critchley HD, Wiens S, Rotshtein P, Ohman A, Dolan RJ. Neural systems supporting interoceptive awareness. Nat Neurosci 2004;7:189-195.
14. Reiman EM. The application of positron emission tomography to the study of normal and pathologic emotions. J Clin Psychiatry 1997;58 suppl 16:4-12.
15. Stein MB, Goldin PR, Sareen J, Zorrilla LT, Brown GG. Increased amygdala activation to angry and contemptuous faces in generalized social phobia. Arch Gen Psychiatry 2002;59:1027-1034.
16. Phan KL, Fitzgerald DA, Nathan PJ, Tancer ME. Association between amygdala hyperactivity to harsh faces and severity of social anxiety in generalized social phobia. Biol Psychiatry 2006;59:424-429.
17. Straube T, Kolassa IT, Glauer M, Mentzel HJ, Miltner WH. Effect of task conditions on brain responses to threatening faces in social phobics: An event-related functional magnetic resonance imaging study. Biol Psychiatry 2004;56:921-930.
18. Evans KC, Wright CI, Wedig MM, Gold AL, Pollack MH, Rauch SL. A functional MRI study of amygdala responses to angry schematic faces in social anxiety disorder. Depress Anxiety 2008;25:496-505.
19. Liebowitz MR. Social phobia. Mod Probl Pharmacopsychiatry 1987;22:141-173.
20. Amir N, Klumpp H, Elias J, Bedwell JS, Yanasak N, Miller LS. Increased activation of the anterior cingulate cortex during processing of disgust faces in individuals with social phobia. Biol Psychiatry 2005;57:975-981.
21. Straube T, Mentzel HJ, Miltner WH. Common and distinct brain activation to threat and safety signals in social phobia. Neuropsychobiology 2005;52:163-168.
22. Cooney RE, Atlas LY, Joormann J, Eugene F, Gotlib IH. Amygdala activation in the processing of neutral faces in social anxiety disorder: Is neutral really neutral? Psychiatry Res 2006;148:55-59.
23. Birbaumer N, Grodd W, Diedrich O, Klose U, Erb M, Lotze M, Schneider F, Weiss U, Flor H. fMRI reveals amygdala activation to human faces in social phobics. NeuroReport 1998;9:1223-1226.
24. Veit R, Flor H, Erb M, Hermann C, Lotze M, Grodd W, Birbaumer N. Brain circuits involved in emotional learning in antisocial behavior and social phobia in humans. Neurosci Lett 2002;328:233-236.
25. Schneider F, Weiss U, Kessler C, Müller-Gärtner H-W, Posse S, Salloum JB, Grodd W, Himmelmann F, Gaebel W, Birbaumer N. Subcortical correlates of differential classical conditioning of aversive emotional reactions in social phobia. Biol Psychiatry 1999;45:863-871.
26. Hermann C, Ziegler S, Birbaumer N, Flor H. Psychophysiological and subjective indicators of aversive Pavlovian conditioning in generalized social phobia. Biol Psychiatry 2002; 52:328-337.
27. Tillfors M, Furmark T, Marteinsdottir I, Fredrikson M. Cerebral blood flow during anticipation of public speaking in social phobia: A PET study. Biol Psychiatry 2002;52:1113-1119.
28. Davidson RJ, Marshall JR, Tomarken AJ, Henriques JB. While a phobic waits: Regional brain electrical and autonomic activity in social phobics during anticipation of public speaking. Biol Psychiatry 2000;47:85-95.
29. Lorberbaum JP, Kose S, Johnson MR, Arana GW, Sullivan LK, Hamner MB, Ballenger JC, Lydiard RB, Brodrick PS, Bohning DE, George MS. Neural correlates of speech anticipatory anxiety in generalized social phobia. Neu- roReport 2004;15:2701-2705.
30. Kilts CD, Kelsey JE, Knight B, Ely TD, Bowman FD, Gross RE, Selvig A, Gordon A, Newport DJ, Nemeroff CB. The neural correlates of social anxiety disorder and response to pharmacotherapy. Neuropsychopharmacology 2006;31:2243-2254.
31. Van Ameringen M, Mancini C, Szechtman H, Nahmias C, Oakman JM, Hall GB, Pipe B, Farvolden P. A PET provocation study of generalized social phobia. Psychiatry Res 2004;132:13-18.
32. Furmark T, Tillfors M, Marteinsdottir I, Fischer H, Pissiota A, Langstrom B, Fredrikson M. Common changes in cerebral blood flow in patients with social phobia treated with citalopram or cognitive-behavioral therapy. Arch Gen Psychiatry 2002;59:425-433.
33. Furmark T, Appel L, Michelgård Å, Wahlstedt K, Åhs F, Zancan S, Jacobsson E, Flyckt K, Grohp M, Bergström M, Merlo Pich E, Nilsson LG, Bani M, Långström B, Fredrikson M. Cerebral blood flow changes after treatment of social phobia with the neurokinin-1 antagonist GR205171, citalopram, or placebo. Biol Psychiatry 2005;58:132-142.
34. Goossens L, Sunaert S. Peeters R, Griez EJ, Schruers KR Amygdala hyperfunction in phobic fear normalizes after exposure. Biol Psychiatry 2007;62:1119-1125.
35. Sheline YI, Barch DM, Donnelly JM, Ollinger JM, Snyder AZ, Mintun MA. Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: An fMRI study. Biol Psychiatry 2001;50:651-658.
36. Harmer CJ, Mackay CE, Reid CB, Cowen PJ, Goodwin GM. Antidepressant drug treatment modifies the neural processing of nonconscious threat cues. Biol Psychiatry 2006;59:816-820.
37. Harmer CJ, Mackay CE, Reid CB, Cowen PJ, Goodwin GM. Antidepressant drug treatment modifies the neural processing of nonconscious threat cues. Biol Psychiatry 2006;59:816-820.
38. Yoon KL, Fitzgerald DA, Angstadt M, McCarron RA, Phan KL. Amygdala reactivity to emotional faces at high and low intensity in generalized social phobia: A 4-Tesla functional MRI study. Psychiatry Res 2007;154:93-98.
39. Etkin A, Wager TD. Functional neuroimaging of anxiety: A meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. Am J Psychiatry 2007;164:1476-1488.
40. Graeff FG. On serotonin and experimental anxiety. Psychopharmacology 2002;163:467-476.
41. Ipser JC, Kariuki CM, Stein DJ. Pharmacotherapy for social anxiety disorder: A systematic review. Expert Rev Neurother 2008;8:235-257.
42. Bauman MD, Amaral DG. The distribution of serotonergic fibers in the macaque monkey amygdala: An immunohistochemical study using antisera to 5-hydroxytryptamine. Neuroscience 2005;36:193-203
43. Hariri AR, Holmes A. Genetics of emotional regulation: The role of the serotonin transporter in neural function. Trends Cogn Sci 2006;10:182-191.
44. Furmark T, Tillfors M, Garpenstrand H, Marteinsdottir I, Langstrom B, Oreland L, Fredrikson M. Serotonin transporter polymorphism related to amygdala excitability and symptom severity in patients with social phobia. Neurosci Lett 2004;362:189-192.
45. Tancer ME. Neurobiology of social phobia. J Clin Psychiatry 1993;54 suppl 12:26-30.
46. Lanzenberger RR, Mitterhauser M, Spindelegger C, Wadsak W, Klein N, Mien LK, Holik A, Attarbaschi T, Mossaheb N, Sacher J, Geiss-Granadia T, Kletter K, Kasper S, Tauscher J. Reduced serotonin-1A receptor binding in social anxiety disorder. Biol Psychiatry 2007;61:1081-1089.
47. Kent JM, Coplan JD, Lombardo I, Hwang DR, Huang Y, Mawlawi O, Van Heertum RL, Slifstein M, Abi-Dargham A, Gorman JM, Laruelle M. Occupancy of brain serotonin transporters during treatment with paroxetine in patients with social phobia: A positron emission tomography study with 11C McN 5652. Psychopharmacology 2002;164:341-348.
48. 11C] 5-hydroxytryptophan. Biol Psychiatry 2007; 61 Suppl. S:50S.
49. Richard IH, Schiffer RB, Kurlan R. Anxiety and Parkinson's disease. J Neuropsychiatry Clin Neurosci 1996;8:383-392.
50. Heydari B, Le Mellédo JM. Low pregnenolone sulphate plasma concentrations in patients with generalized social phobia. Psychol Med 2002;32:929-933.
51. Grant KA, Shively CA, Nader MA, Ehrenkaufer RL, Line SW, Morton TE, Gage HD, Mach RH. Effect of social status on striatal dopamine D2 receptor binding characteristics in cynomolgus monkeys assessed with positron emission tomography. Synapse 1998;29:80-83.
52. Sareen J, Campbell DW, Leslie WD, Malisza KL, Stein MB, Paulus MP, Kravetsky LB, Kjernisted KD, Walker JR, Reiss JP. Striatal function in generalized social phobia: A functional magnetic resonance imaging study. Biol Psychiatry 2007;61:396-404.
53. Tiihonen J, Kuikka J, Bergström K, Lepola U, Koponen H, Leinonen E. Dopamine reuptake site densities in patients with social phobia. Am J Psychiatry 1997;154:239-242.
54. 2 receptor binding potential in social phobia. Am J Psychiatry 2000;157:457-459.
55. Stein MB, Gelernter J, Smoller JW. Genetics of social anxiety disorder and related traits. In: Bandelow B, Stein DJ, editors. Social anxiety disorder. New York: Marcel Dekker, 1994: pp. 197-214.
56. Serretti A, Calati R, Mandelli L, De Ronchi D. Serotonin transporter gene variants and behavior: A comprehensive review. Curr Drug Targets 2006;7:1659-1669.
57. Stein MB, Seedat S, Gelernter J. Serotonin transporter gene promoter polymorphism predicts SSRI response in generalized social anxiety disorder. Psychopharmacology 2006;187:68-72.
58. Brown SM, Peet E, Manuck SB, Williamson DE, Dahl RE, Ferrell RE, Hariri AR. A regulatory variant of the human tryptophan hydroxylase-2 gene biases amygdala reactivity. Mol Psychiatry 2005;10:884-888. (Pubitemid 43080123)
59. Smolka MN, Schumann G, Wrase J, Grüsser SM, Flor H, Mann K, Braus DF, Goldman D, Büchel C, Heinz A. Catechol-O-methyltransferase val158met genotype affects processing of emotional stimuli in the amygdala and prefrontal cortex. J Neurosci 2005;25:836-842.